We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current IONS market cap is 6.19B. The company's latest EPS is USD -2.5131 and P/E is -16.89.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 159.77M | 151.89M | 130.52M | 188.41M | 144.21M |
| Operating Income | -59.16M | -208.02M | -114.15M | -90.2M | -143.26M |
| Net Income | -46.99M | -52.43M | -124.32M | -85.29M | -147.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.12B | 729.26M | 810.46M | 587.37M | 787.65M |
| Operating Income | 365.88M | -172.08M | -30.19M | -410.19M | -353.73M |
| Net Income | 294.15M | -451.29M | -28.6M | -269.72M | -366.29M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.42B | 2.53B | 2.89B | 2.97B | 2.93B |
| Total Liabilities | 1.83B | 1.96B | 2.4B | 2.54B | 2.62B |
| Total Equity | 594.36M | 572.89M | 486.57M | 428.3M | 315.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.23B | 2.39B | 2.61B | 2.53B | 2.99B |
| Total Liabilities | 1.55B | 1.55B | 1.84B | 1.96B | 2.6B |
| Total Equity | 1.68B | 843.35M | 771.74M | 572.89M | 386.69M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -74.18M | -274.37M | -133.99M | -231.36M | -340.38M |
| Investing | -474.78M | -262.64M | -325.64M | -256.13M | -187.41M |
| Financing | -4.28M | -55.3M | 492.09M | 635.63M | 603.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 345.72M | 35.89M | 30.8M | -274.37M | -307.51M |
| Investing | -41.27M | 274.48M | 194.91M | -262.64M | -214.13M |
| Financing | 100.02M | -596.61M | 245.93M | -55.3M | 644.08M |
| Market Cap | 6.19B |
| Price to Earnings Ratio | -16.89 |
| Price to Sales Ratio | 7.86 |
| Price to Cash Ratio | 15.5 |
| Price to Book Ratio | 16 |
| Dividend Yield | - |
| Shares Outstanding | 145.75M |
| Average Volume (1 week) | 780.92k |
| Average Volume (1 Month) | 942.64k |
| 52 Week Change | 18.71% |
| 52 Week High | 54.4446 |
| 52 Week Low | 34.32 |
| Spread (Intraday) | 9.99 (19.98%) |
| Company Name | Ionis Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.isispharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
